Search Results - "Coltelli L"

290P From the CLEOPATRA study to real life: Final results from the G.O.N.O. SUPER trial.

Authors: Garrone, O. Giarratano, T. Michelotti, A. et al.

Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS358-S358. 1p.

335P - Safety and efficacy of ribociclib (RIBO) + letrozole (LET) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC): Interim results from the Italian cohort of the CompLEEment-1 (C-1) study

Authors: De Laurentiis, M. Mazza, M. Mansutti, M. et al.

Source: Annals of Oncology. 2019 Supplement 6, Vol. 30, pv119-v119. 1p.

333P - Ribociclib (RIB) + letrozole (LET) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor-2–negative (HER2–) advanced breast cancer (ABC) and central nervous system (CNS) metastases: Subgroup analysis from the phase IIIb CompLEEment-1 trial

Authors: Cottu, P.H. De Laurentiis, M. Marchetti, P. et al.

Source: Annals of Oncology. 2019 Supplement 6, Vol. 30, pv118-v118. 1p.

Mixed endometrial carcinoma: is it time to profile the two components separately?

Authors: Musettini G Pretelli P Giusti A et al.

Source: Frontiers in oncology [Front Oncol] 2026 Apr 23; Vol. 16, pp. 1735988. Date of Electronic Publication: 2026 Apr 23 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Bevacizumab and Paclitaxel in Advanced, Hormone Receptor-Positive Breast Cancer: Multifactor Dimensionality Reduction Methodology to Identify Best Overall Survival.

Authors: Coltelli L Orlandi P Finale C et al.

Source: Oncology research [Oncol Res] 2026 Apr 22; Vol. 34 (5), pp. 13. Date of Electronic Publication: 2026 Apr 22 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Tech Science Press Country of Publication: United States NLM ID: 9208097 Publication Model: eCollection Cited Medium: Internet ISSN: 1555-3906 (Electronic) Linking ISSN: 09650407 NLM ISO Abbreviation: Oncol Res Subsets: MEDLINE

Current Landscape and Evolving Role of Targeted Agents in Urothelial Carcinoma.

Authors: Sammarco E Pellino A Bona E et al.

Source: Cancers [Cancers (Basel)] 2026 Jan 28; Vol. 18 (3). Date of Electronic Publication: 2026 Jan 28.

Publication Type: Journal Article; Review

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Second-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study.

Authors: Cazzaniga ME Cogliati V Rossi E et al.

Source: ESMO real world data and digital oncology [ESMO Real World Data Digit Oncol] 2026 Jan 06; Vol. 11, pp. 100665. Date of Electronic Publication: 2026 Jan 06 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 9919053637506676 Publication Model: eCollection Cited Medium: Internet ISSN: 2949-8201 (Electronic) Linking ISSN: 29498201 NLM ISO Abbreviation: ESMO Real World Data Digit Oncol Subsets: PubMed not MEDLINE

Management of the axilla in breast cancer patients: critical review, regional modified Delphi consensus and implementation in the Tuscan breast network.

Authors: Ghilli M Becherini C Meattini I et al.

Source: La Radiologia medica [Radiol Med] 2024 Jun; Vol. 129 (6), pp. 945-954. Date of Electronic Publication: 2024 Apr 29.

Publication Type: Journal Article; Review; Consensus Statement

Journal Info: Publisher: Springer Milan Country of Publication: Italy NLM ID: 0177625 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1826-6983 (Electronic) Linking ISSN: 00338362 NLM ISO Abbreviation: Radiol Med Subsets: MEDLINE

Non-pegylated liposomal doxorubicin in older adjuvant early breast cancer patients: cardiac safety analysis and final results of the COLTONE study.

Authors: Coltelli L Finale C Musettini G et al.

Source: Clinical and experimental medicine [Clin Exp Med] 2023 Dec; Vol. 23 (8), pp. 5113-5120. Date of Electronic Publication: 2023 Aug 27.

Publication Type: Journal Article

Journal Info: Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1591-9528 (Electronic) Linking ISSN: 15918890 NLM ISO Abbreviation: Clin Exp Med Subsets: MEDLINE

Cardioprotection in patients with anthracycline-treated breast cancer: final analysis from the 2 × 2 randomized, placebo-controlled, double-blind SAFE trial.

Authors: Meattini I Becherini C Martella F et al.

Source: ESMO open [ESMO Open] 2025 Jun; Vol. 10 (6), pp. 105116. Date of Electronic Publication: 2025 May 21.

Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2- Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 Study.

Authors: De Laurentiis M Caputo R Mazza M et al.

Source: Targeted oncology [Target Oncol] 2022 Nov; Vol. 17 (6), pp. 615-625. Date of Electronic Publication: 2022 Sep 24.

Publication Type: Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE

A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients.

Authors: Coltelli L Allegrini G Orlandi P et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2022 Mar 21; Vol. 8 (1), pp. 33. Date of Electronic Publication: 2022 Mar 21.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE.

Authors: Leo S Arnoldi E Repetto L et al.

Source: The oncologist [Oncologist] 2019 Jun; Vol. 24 (6), pp. e232-e240. Date of Electronic Publication: 2018 Nov 09.

Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Real-World Clinical Outcomes of Ribociclib in Combination with a Non-Steroidal Aromatase Inhibitor and a Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal HR+/HER2- Advanced Breast Cancer Patients: An Italian Managed Access Program.

Authors: Staropoli N Geuna E Rinaldi G et al.

Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Sep 17; Vol. 29 (9), pp. 6635-6641. Date of Electronic Publication: 2022 Sep 17.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729 (Electronic) Linking ISSN: 11980052 NLM ISO Abbreviation: Curr Oncol Subsets: MEDLINE

Cardioprotective Strategy for Patients With Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial.

Authors: Livi L Barletta G Martella F et al.

Source: JAMA oncology [JAMA Oncol] 2021 Oct 01; Vol. 7 (10), pp. 1544-1549.

Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized Phase 2 Clinical Trial.

Authors: Cremolini C Antoniotti C Lonardi S et al.

Source: JAMA oncology [JAMA Oncol] 2018 Apr 01; Vol. 4 (4), pp. 529-536.

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

Cardiac safety of adjuvant non-pegylated liposomal doxorubicin combined with cyclophosphamide and followed by paclitaxel in older breast cancer patients.

Authors: Coltelli L Fontana A Lucchesi S et al.

Source: Breast (Edinburgh, Scotland) [Breast] 2017 Feb; Vol. 31, pp. 186-191. Date of Electronic Publication: 2016 Nov 23.

Publication Type: Clinical Trial, Phase II; Journal Article

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE

Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients.

Authors: Solini A Simeon V Derosa L et al.

Source: Oncotarget [Oncotarget] 2015 Oct 06; Vol. 6 (30), pp. 28743-54.

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab.

Authors: Allegrini G Coltelli L Orlandi P et al.

Source: Pharmacogenomics [Pharmacogenomics] 2014 Dec; Vol. 15 (16), pp. 1985-99.

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 100897350 Publication Model: Print Cited Medium: Internet ISSN: 1744-8042 (Electronic) Linking ISSN: 14622416 NLM ISO Abbreviation: Pharmacogenomics Subsets: MEDLINE

Discordant somatic and germline VEGF-A genotype in a cancer patient resistant to paclitaxel/bevacizumab with chemosensitive hepatic metastasis.

Authors: Coltelli L Allegrini G Orlandi P et al.

Source: Pharmacogenomics [Pharmacogenomics] 2009 Aug; Vol. 10 (8), pp. 1225-9.

Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 100897350 Publication Model: Print Cited Medium: Internet ISSN: 1744-8042 (Electronic) Linking ISSN: 14622416 NLM ISO Abbreviation: Pharmacogenomics Subsets: MEDLINE